Caricamento...
Neuropharmacological Actions of Metformin in Stroke
Increasing epidemiologic evidence suggests that metformin, a well-established AMPK activator and the most favorable first-line anti-diabetic drug, reduces stroke incidence and severity. However, the mechanism for this remains unclear. Moreover, previous experimental studies have reported controversi...
Salvato in:
| Pubblicato in: | Curr Neuropharmacol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Bentham Science Publishers
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4812800/ https://ncbi.nlm.nih.gov/pubmed/26411966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X13666150205143555 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|